These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10395383)

  • 1. Potential risk of inadvertent germ-line gene transmission statement from the American Society of Gene Therapy to the NIH Recombinant DNA Advisory Committee, March 12, 1999.
    Wilson JM; Wivel NA
    Hum Gene Ther; 1999 Jun; 10(9):1593-5. PubMed ID: 10395383
    [No Abstract]   [Full Text] [Related]  

  • 2. NIH Recombinant DNA Advisory Committee data management report. March 12, 1999.
    Hum Gene Ther; 1999 Jun; 10(9):1577-89. PubMed ID: 10395382
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee.
    Hum Gene Ther; 2002 Jan; 13(1):3-13. PubMed ID: 11779411
    [No Abstract]   [Full Text] [Related]  

  • 4. NIH Recombinant DNA Advisory Committee data management report. June 18-19, 1998.
    Hum Gene Ther; 1998 Sep; 9(14):2143-61. PubMed ID: 9759940
    [No Abstract]   [Full Text] [Related]  

  • 5. Future oversight of recombinant DNA research: recommendations of an Institute of Medicine committee.
    Gostin LO; Altevogt BM; Pope AM
    JAMA; 2014 Feb; 311(7):671-2. PubMed ID: 24435443
    [No Abstract]   [Full Text] [Related]  

  • 6. Supervising gene therapy, openly.
    Lancet; 1997 Jul; 350(9071):79. PubMed ID: 9228953
    [No Abstract]   [Full Text] [Related]  

  • 7. The National Institutes of Health Oversight of Human Gene Transfer Research: Enhancing Science and Safety.
    O'Reilly M; Jambou R; Rosenthal E; Montgomery M; Hassani M; Gargiulo L; Corrigan-Curay J
    Adv Exp Med Biol; 2015; 871():31-47. PubMed ID: 26374211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Institutes of Health Recombinant DNA Advisory Committee (RAC). 91st meeting of the NIH RAC, Bethesda Marriott Hotel, Bethesda, Maryland, June 18-19, 20003.
    National Institutes of Health Recombinant DNA Advisory Committee
    Hum Gene Ther; 2003 Sep; 14(14):1361-5. PubMed ID: 14552317
    [No Abstract]   [Full Text] [Related]  

  • 9. NIH oversight of human gene transfer research involving retroviral, lentiviral, and adeno-associated virus vectors and the role of the NIH recombinant DNA advisory committee.
    O'Reilly M; Shipp A; Rosenthal E; Jambou R; Shih T; Montgomery M; Gargiulo L; Patterson A; Corrigan-Curay J
    Methods Enzymol; 2012; 507():313-35. PubMed ID: 22365781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. U.S. Department of Health and Human Services, National Institutes of Health. Recombinant DNA Advisory Committee: minutes of meeting, December 13 & 15, 2000.
    Hum Gene Ther; 2001 Aug; 12(12):1559-84. PubMed ID: 11506698
    [No Abstract]   [Full Text] [Related]  

  • 11. Petition to amend the National Institutes of Health Guidelines for Research Involving Recombinant DNA Molecules to establish a Public Policy Advisory Committee. Foundation on Economic Trends, September 18, 1990.
    Hum Gene Ther; 1991; 2(2):131-4. PubMed ID: 1911933
    [No Abstract]   [Full Text] [Related]  

  • 12. Who needs to know? Confusion reigns over the reporting of gene therapy deaths.
    Boyce N
    New Sci; 1999 Nov; 164(2212):15. PubMed ID: 11885629
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulatory concerns in human gene therapy.
    Epstein SL
    Hum Gene Ther; 1991; 2(3):243-9. PubMed ID: 1751592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy on the RAC.
    Steele FR
    Mol Ther; 2000 Jan; 1(1):1-2. PubMed ID: 10933902
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene therapy in the United States: a five-year status report.
    Ross G; Erickson R; Knorr D; Motulsky AG; Parkman R; Samulski J; Straus SE; Smith BR
    Hum Gene Ther; 1996 Sep; 7(14):1781-90. PubMed ID: 8886849
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene therapy death prompts review of adenovirus vector.
    Marshall E
    Science; 1999 Dec; 286(5448):2244-5. PubMed ID: 10636774
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene-splice oversight.
    Parens E
    Washington Post; 1996 Jun; ():A21. PubMed ID: 11646331
    [No Abstract]   [Full Text] [Related]  

  • 18. Lentiviral vectors approach the clinic but fall back: National Institutes of Health Recombinant DNA Advisory Committee review of a first clinical protocol for use of a lentiviral vector.
    Podsakoff GM
    Mol Ther; 2001 Oct; 4(4):282-3. PubMed ID: 11592827
    [No Abstract]   [Full Text] [Related]  

  • 19. Department of Health and Human Services. Recombinant DNA Advisory Committee. National Institutes of Health. Minutes of Meeting. June 14, 1999.
    Hum Gene Ther; 2000 Jun; 11(9):1369-82. PubMed ID: 11032449
    [No Abstract]   [Full Text] [Related]  

  • 20. Department of Health and Human Services. National Institutes of Health. Recombinant DNA Advisory Committee. Minutes of meeting. March 6-7, 1997.
    Hum Gene Ther; 1997 Nov; 8(16):1955-2004. PubMed ID: 9382961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.